![Feng Chun Qi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Feng Chun Qi
Chief Executive Officer at Jilin Wanfang Baiao Biotechnology Co., Ltd.
Profile
Feng Chun Qi currently works as a General Manager & Director at Jilin Wanfang Baiao Biotechnology Co., Ltd.
Feng Chun Qi active positions
Companies | Position | Start |
---|---|---|
Jilin Wanfang Baiao Biotechnology Co., Ltd.
![]() Jilin Wanfang Baiao Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Vanfund Urban Investment & Development Co., Ltd., Jilin Wanfang Baiao Biotechnology Co., Ltd. manufactures and sells pharmaceutical products. The company is based in Changchun, China. The Chinese company was founded in 2020. The CEO is Feng Chun Qi. Jilin Wanfang Baiao Biotechnology Co. was acquired by Vanfund Urban Investment & Development Co., Ltd. on January 26, 2022 for $3.29 million. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Jilin Wanfang Baiao Biotechnology Co., Ltd.
![]() Jilin Wanfang Baiao Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Vanfund Urban Investment & Development Co., Ltd., Jilin Wanfang Baiao Biotechnology Co., Ltd. manufactures and sells pharmaceutical products. The company is based in Changchun, China. The Chinese company was founded in 2020. The CEO is Feng Chun Qi. Jilin Wanfang Baiao Biotechnology Co. was acquired by Vanfund Urban Investment & Development Co., Ltd. on January 26, 2022 for $3.29 million. | Health Technology |
- Stock Market
- Insiders
- Feng Chun Qi